FORTERRA INC (FRTA)

Common Stock

24  +0.93 (+4.03%)

After market: 23.99 -0.01 (-0.04%)

Fundamental Rating

2

Taking everything into account, FRTA scores 2 out of 10 in our fundamental rating. FRTA was compared to 12 industry peers in the Construction Materials industry. FRTA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FRTA is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year FRTA was profitable.
The reported net income has been mixed in the past 5 years: FRTA reported negative net income in multiple years.
FRTA had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 11.69%
PM (TTM) 6.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRTA has more shares outstanding
FRTA has a better debt/assets ratio than last year.

2.2 Solvency

FRTA has an Altman-Z score of 2.39. This is not the best score and indicates that FRTA is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 3.20 is on the high side and indicates that FRTA has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.15 indicates that FRTA has no problem at all paying its short term obligations.
A Quick Ratio of 1.25 indicates that FRTA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.25

4

3. Growth

3.1 Past

FRTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.57%, which is quite impressive.
FRTA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.53%.
The Revenue has been growing slightly by 6.38% on average over the past years.
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q12.12%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y6.38%
Revenue growth Q2Q23.91%

3.2 Future

The Earnings Per Share is expected to grow by 16.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.94% on average over the next years.
EPS Next Y17.88%
EPS Next 2Y15.65%
EPS Next 3Y15.92%
EPS Next 5Y16.63%
Revenue Next Year2.44%
Revenue Next 2Y2.45%
Revenue Next 3Y1.77%
Revenue Next 5Y1.94%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.37, the valuation of FRTA can be described as correct.
The average S&P500 Price/Earnings ratio is at 24.55. FRTA is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.19, the valuation of FRTA can be described as correct.
FRTA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.92.
Industry RankSector Rank
PE 14.37
Fwd PE 12.19

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.69

4.3 Compensation for Growth

FRTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FRTA's earnings are expected to grow with 15.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y15.65%
EPS Next 3Y15.92%

0

5. Dividend

5.1 Amount

No dividends for FRTA!.
Industry RankSector Rank
Dividend Yield N/A

FORTERRA INC

NASDAQ:FRTA (3/17/2022, 8:00:00 PM)

After market: 23.99 -0.01 (-0.04%)

24

+0.93 (+4.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.61B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE 12.19
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.69%
PM (TTM) 6.26%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.15
Quick Ratio 1.25
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y17.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y